XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort (XVU-AV DAPT)
This study has been completed.
Sponsor:
Abbott Vascular
Collaborators:
Harvard Clinical Research Institute
Bristol-Myers Squibb
Eli Lilly and Company
Daiichi Sankyo Inc.
Information provided by (Responsible Party):
Abbott Vascular
ClinicalTrials.gov Identifier:
NCT01106534
First received: April 16, 2010
Last updated: September 11, 2013
Last verified: September 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2013 |
| Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |